Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma.

Saved in:

Bibliographic Details
Title:	Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma.
Authors:	Santoni, M¹, De Giorgi, U², Iacovelli, R³, Conti, A⁴, Burattini, L¹, Rossi, L², Luca Burgio, S², Berardi, R¹, Muzzonigro, G⁴, Cortesi, E³, Amadori, D², Cascinu, S¹
Source:	British Journal of Cancer. 10/1/2013, Vol. 109 Issue 7, p1755-1759. 5p.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2013.522